Comparison

BCR-ABL kinase-IN-3 (dihydrocholide) European Partner

Item no. HY-160174A
Manufacturer MedChem Express
Amount 1 ea
Specific against other
Citations [1]Lee Doohyun, et al. Preparation of 3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethynyl)-N-phenylbenzamide derivatives for prevention or treatment of cancer. World Intellectual Property Organization, WO2021172931 A1 2021-09-02
Smiles CN(N=C1)C=C1NC2=CC=CN3C2=NC=C3C#CC4=C(C)C=C(F)C(C(NC5=CC(N6C=C(C)N=C6)=CC(C(C#N)(C)C)=C5)=O)=C4.[H]Cl.[H]Cl
Available
Product Description
BCR-ABL kinase-IN-3 (dihydrocholide) (example 1) is a potent inhibitor of BCR-ABL that plays an important role in acute myeloid leukemia (AML) research[1].
Shipping
Room temperature
Manufacturers Applications
Cancer-Kinase/protease
MolecularWeight
684.59
Clinical Information
No Development Reported
Manufacturers Research Area
cancer
Solubility
10 mM in DMSO
Target
Bcr-Abl
Manufacturers Target
Bcr-Abl
Manufacturers Pathway
Protein Tyrosine Kinase/RTK
Manufacturers Product type
Reference compound

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 ea
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close